HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

naroparcil

Also Known As:

(4-(4-cyanobenzoyl)phenyl)-1,5-dithio-beta-D-xylopyranoside

Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Sulfur Compounds: 278
  - Thioglycosides: 17
    - naroparcil: 2
Carbohydrates: 22023
- Glycosides: 2119
  - Thioglycosides: 17
    - naroparcil: 2

Related Diseases

1.	Hyperplasia 11/01/1995 - "This study evaluated whether treatment with naroparcil, a beta-D-xyloside analogue, reduced intimal hyperplasia after arterial injury in the hypercholesterolemic rabbit. " 11/01/1995 - "Reduction of intimal hyperplasia by naroparcil, a 4-methylumbelliferyl beta-D-xyloside analogue, after arterial injury in the hypercholesterolemic rabbit."
2.	Venous Thrombosis (Deep-Vein Thrombosis) 12/01/1994 - "Naroparcil attenuated thrombus development in a Wessler stasis model of venous thrombosis (jugular vein) employing bovine factor Xa as a thrombogenic stimulus giving ED50 values of 21.9 mg/kg and 36.0 mg/kg after respectively i.v. and oral administration. "
3.	Thrombosis (Thrombus) 12/01/1994 - "Naroparcil attenuated thrombus development in a Wessler stasis model of venous thrombosis (jugular vein) employing bovine factor Xa as a thrombogenic stimulus giving ED50 values of 21.9 mg/kg and 36.0 mg/kg after respectively i.v. and oral administration. "

Related Drugs and Biologics

1.	xylosides
2.	Factor Xa (Coagulation Factor Xa)

Related Therapies and Procedures

1.	Oral Administration